FALCIANI, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 5.575
NA - Nord America 5.547
AS - Asia 1.036
SA - Sud America 109
AF - Africa 15
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.302
Nazione #
US - Stati Uniti d'America 5.518
GB - Regno Unito 1.541
IT - Italia 986
IE - Irlanda 870
CN - Cina 623
SE - Svezia 520
UA - Ucraina 440
RU - Federazione Russa 342
DE - Germania 309
FR - Francia 223
SG - Singapore 178
FI - Finlandia 124
BR - Brasile 92
VN - Vietnam 82
ES - Italia 68
BE - Belgio 51
PL - Polonia 24
CA - Canada 23
IR - Iran 23
IN - India 22
CZ - Repubblica Ceca 18
TR - Turchia 18
HK - Hong Kong 16
PK - Pakistan 13
NL - Olanda 12
AU - Australia 11
BD - Bangladesh 10
AT - Austria 9
PH - Filippine 8
RO - Romania 8
JP - Giappone 7
PE - Perù 7
CI - Costa d'Avorio 6
EU - Europa 6
IL - Israele 6
DK - Danimarca 5
EG - Egitto 5
UZ - Uzbekistan 4
AZ - Azerbaigian 3
CL - Cile 3
EC - Ecuador 3
EE - Estonia 3
JO - Giordania 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MA - Marocco 3
MX - Messico 3
NZ - Nuova Zelanda 3
RS - Serbia 3
SA - Arabia Saudita 3
VE - Venezuela 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CH - Svizzera 2
KG - Kirghizistan 2
LT - Lituania 2
PA - Panama 2
SI - Slovenia 2
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
JM - Giamaica 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
MT - Malta 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 12.302
Città #
Southend 1.445
Dublin 861
Fairfield 662
Chandler 481
Ashburn 419
Siena 415
Jacksonville 361
Woodbridge 341
Santa Clara 333
Ann Arbor 297
Wilmington 270
Seattle 265
Houston 264
Menlo Park 234
Cambridge 211
Beijing 157
Princeton 143
Singapore 124
Nanjing 112
Dong Ket 81
Boardman 75
New York 73
Florence 61
Málaga 60
Helsinki 55
San Mateo 54
Shanghai 53
Nanchang 48
Rome 44
San Diego 44
Fremont 40
Brussels 37
Dearborn 34
Milan 33
Hebei 30
Redwood City 28
Shenyang 28
Council Bluffs 25
Kunming 23
Tianjin 22
Bagno a Ripoli 21
Moscow 21
Washington 21
Los Angeles 20
London 19
Brno 17
Jiaxing 16
Toronto 16
Changsha 14
Düsseldorf 14
Gdansk 14
Izmir 13
Ningbo 13
Dallas 12
Kansas City 12
Phoenix 12
São Paulo 12
Chicago 11
Zhengzhou 11
Jinan 9
University Park 9
Catania 8
Guangzhou 8
Hangzhou 8
Hong Kong 8
Norwalk 8
Nuremberg 8
Taizhou 8
Venezia 8
Zanjan 8
Arezzo 7
Belo Horizonte 7
Colle Di Val D'elsa 7
Columbus 7
Ghent 7
Lancaster 7
Lima 7
Munich 7
San Francisco 7
Vienna 7
Abidjan 6
Atlanta 6
Frankfurt am Main 6
Grosseto 6
Lappeenranta 6
Nürnberg 6
Overijse 6
Tappahannock 6
Auburn Hills 5
Campagnano Di Roma 5
Lanzhou 5
Manila 5
Naples 5
Piscataway 5
Radomsko 5
Stockholm 5
Waukegan 5
Cairo 4
Changchun 4
Dhaka 4
Totale 8.897
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 273
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 270
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 265
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 263
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions. 228
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 220
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 219
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 211
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 208
Tumor imaging with tetrabranched neurotensin 207
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 207
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 206
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 205
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 200
A new NT4 peptide-based drug delivery system for cancer treatment 194
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 183
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 182
Branched peptides for tumor diagnosis and therapy 178
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 178
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 176
Branched Neurotensin For Tumor Targeting 175
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 175
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 174
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 172
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 171
Branched peptides as bioactive molecules for drug design 170
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 169
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 167
Synthetic peptides in the form of dendrimers become resistant to protease activity 165
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 162
Exploration of novel thiobarbituric acid- rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors 160
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 160
The development of antimicrobial peptides as new antibacterial drugs 160
Bioactive peptides from libraries 156
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 153
Branched peptides as targeting agents for tumor imaging and therapy 152
Branched multimeric peptides for tumor diagnosis and therapy 150
Nanoparticles exposing neurotensin tumor-specific drivers 147
Branched neurotensin for tumor targeting 146
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 146
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 144
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 140
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 139
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 137
Molecular basis of branched peptides resistance to enzyme proteolysis 134
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 133
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 132
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 132
Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles 130
Neurotensin-derived branched peptides and uses thereof 128
Branched Neurotensin peptides for tumor personalized therapy 128
Synthetic antidotes against snake neurotoxins 126
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 125
BRANCHED PEPTIDES AS THERAPEUTICS 125
Tumor imaging with tetrabranched neurotensin 125
The antimicrobial peptide M33. An example of drug development 124
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 124
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 122
Tumor selective targeting by branched peptides 120
The antimicrobial peptide M33. An example of drug development 119
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 115
Branched peptides as novel tumor-targeting agents for bladder cancer 113
A Multidisciplinary Approach for the Identification ofNovel HIV-1 Non-Nucleoside Reverse TranscriptaseInhibitors: S-DABOCs and DAVPs 110
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 110
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 109
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 105
null 105
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 102
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. 99
Branched neurotensin peptides for tumor targeting 98
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection 96
Synthetic peptides in the form of dendrimers can become resistant to protease activity 95
NMR and MD studies on the interaction between ligand peptides and alpha-bungarotoxin 94
Synthetic inhibitors of anthrax lethal toxin 92
Oligo-branched peptides for tumor targeting: From magic bullets to magic forks 92
Dendrimeric peptides for tumor targeting 81
null 78
STRONG SYNTHETIC INHIBITORS OF ANTHRAX LETHAL TOXIN 74
Peptide Drugs 68
Structurally driven selection of human hepatitis C virus mimotopes. 65
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 63
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 62
Rationally designed affinity maturation of a synthetic antidote against alpha-bungarotoxin 54
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 52
The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide 51
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 50
Extracellular Vesicles of Pseudomonas: Friends and Foes 35
Models of in-vivo Bacterial Infections for the Development of Antimicrobial Peptide-Based Drugs 35
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 33
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 32
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 30
Are periodontitis and psoriasis associated? A pre-clinical murine model 25
Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer 24
Totale 12.537
Categoria #
all - tutte 40.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.849


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020824 0 0 0 0 0 0 0 236 182 197 77 132
2020/20212.063 85 157 42 164 71 279 210 273 177 285 131 189
2021/20221.246 77 122 79 132 85 51 51 77 48 151 127 246
2022/20231.766 94 186 217 226 188 337 41 145 142 82 79 29
2023/20241.406 45 41 125 81 61 392 489 29 7 27 18 91
2024/20251.427 56 130 330 173 351 157 119 111 0 0 0 0
Totale 12.537